Its mRNA and protein were enriched in the tumor samples, and a higher level of the mRNA was related to poorer prognosis, indicating that MRPL44 is a tumor-promoting gene, and its autoantibody may play an anti-tumor role. The gene discussed is MRPL44; the disease is neoplasm.